Free Standard AU & NZ Shipping For All Book Orders Over $80!
Register      Login
Australian Journal of Chemistry Australian Journal of Chemistry Society
An international journal for chemical science
Shopping Cart: ( empty )
You are here: Home > Journals > CH > CH20018 > Fulltext
RESEARCH ARTICLE
Contents Vol 74(2)

Temozolomide-Loaded Solid Lipid Nanoparticles@Hydrogel for Local Treatment of Tumour

Weiwei Ji A and Zhilan Liu https://orcid.org/0000-0001-7333-1407 A B
+ Author Affiliations
- Author Affiliations

A Key Laboratory of Biomedical Polymers of the Ministry of Education and College of Chemistry and Molecular Sciences, Wuhan University, Wuhan 430072, China.

B Corresponding author. Email: liuzl@whu.edu.cn

Australian Journal of Chemistry 74(2) 125-134 https://doi.org/10.1071/CH20018
Submitted: 17 January 2020  Accepted: 6 May 2020   Published: 15 July 2020

Abstract

Temozolomide (TMZ) is a significant anticancer agent especially for chemotherapy of glioblastoma. In order to reduce the recurrence rate of cancer, in this work an injectable hydrogel composed of TMZ-loaded solid lipid nanoparticles (SLNs) was designed for filling the cavity of a glioblastoma operation. First, TMZ-loaded SLNs (T-SLNs) were prepared by emulsion solvent diffusion and evaporation technology. The optimised formulation showed a particle size of 190.8 ± 15.3 nm, a Zeta potential of −20.2 ± 1.7 mV, an entrapment efficiency (EE%) of 99.3 ± 0.5 %, and drug loading (DL%) of 15.1 ± 2.7 %. The optimised formulation was freeze-dried and characterised by scanning electron microscopy (SEM), differential thermogravimetry (DTG), X-ray diffraction (XRD), and stability tests. The freeze-dried T-SLNs were then incorporated into a hydroxypropyl chitosan (HPCS)/diarylaldehyde PEG (PEG-DF) hydrogel bonded with an MRI contrast agent. The hydrogels were evaluated for in vitro drug release and cytotoxicity. The results indicated that compared with free TMZ, the T-SLNs@hydrogel prolonged drug release, and both blank SLNs and hydrogel materials did not exhibit cytotoxicity, suggesting the therapeutic efficacy of TMZ was reserved. Thus, comparing with its conventional oral administration, the obtained TMZ-loaded SLNs and the hydrogel could be more potent for local treatment of glioblastoma after an operation.


References

[1]  C. Fang, K. Wang, Z. R. Stephen, Q. X. Mu, F. M. Kievit, D. T. Chiu, O. W. Press, M. Q. Zhang, ACS Appl. Mater. Interfaces 2015, 7, 6674.
         | Crossref | GoogleScholarGoogle Scholar | 25751368PubMed |

[2]  R. Stupp, M. E. Hegi, W. P. Mason, M. J. van den Bent, M. J. B. Taphoorn, R. C. Janzer, S. K. Ludwin, A. Allgeier, B. Fisher, K. Belanger, P. Hau, A. A. Brandes, J. Gijtenbeek, C. Marosi, C. J. Vecht, K. Mokhtari, P. Wesseling, S. Villa, E. Eisenhauer, T. Gorlia, M. Weller, D. Lacombe, J. G. Cairncross, R. O. Mirimanoff, Lancet Oncol. 2009, 10, 459.
         | Crossref | GoogleScholarGoogle Scholar | 19269895PubMed |

[3]  I. C. Lopes, S. C. B. de Oliveira, A. M. Oliveira-Brett, J. Electroanal. Chem. 2013, 704, 183.
         | Crossref | GoogleScholarGoogle Scholar |

[4]  S. S. Al-Taweel, H. Sabit, H. Eissa, S. E. Abdel-Ghany, G. M. Nasr, M. M. El-Zawahri, Indo Am. J. Pharm. Sci. 2019, 6, 4781.

[5]  L. Cheng, S. D. Bao, J. N. Rich, Biochem. Pharmacol. 2010, 80, 654.
         | Crossref | GoogleScholarGoogle Scholar | 20457135PubMed |

[6]  D. Cosentini, G. Badalamenti, S. Grisanti, V. Basile, I. Rapa, S. Cerri, A. Spallanzani, P. Perotti, E. Musso, M. Lagana, V. D. Ferrari, G. Luppi, A. D. Volta, L. Incorvaia, S. Sigala, A. Russo, M. Volante, M. Terzolo, A. Berruti, Eur. J. Endocrinol. 2019, 181, 681.
         | Crossref | GoogleScholarGoogle Scholar | 31639772PubMed |

[7]  C. Silva-Hirschberg, H. Hartman, S. Stack, S. Swenson, R. O. Minea, M. A. Davitz, T. C. Chen, A. H. Schonthal, Ther. Adv. Med. Oncol. 2019, 11, 1.
         | Crossref | GoogleScholarGoogle Scholar |

[8]  N. Clemente, B. Ferrara, C. L. Gigliotti, E. Boggio, M. T. Capucchio, E. Biasibetti, D. Schiffer, M. Mellai, L. Annovazzi, L. Cangemi, E. Muntoni, G. Miglio, U. Dianzani, L. Battaglia, C. Dianzani, Int. J. Mol. Sci. 2018, 19, 255.
         | Crossref | GoogleScholarGoogle Scholar |

[9]  Y. P. Ramirez, J. L. Weatherbee, R. T. Wheelhouse, A. H. Ross, Pharmaceuticals 2013, 6, 1475.
         | Crossref | GoogleScholarGoogle Scholar | 24287492PubMed |

[10]  N. M. Leguisamo, H. C. Gloria, A. N. Kalil, T. V. Martins, D. B. Azambuja, L. B. Meira, J. Saff, Oncotarget 2017, 8, 54199.
         | Crossref | GoogleScholarGoogle Scholar | 28903334PubMed |

[11]  G. M. G. Fortuna, K. Dvir, C. Febres-Aldana, M. Schwartz, A. M. Medina, J. Investig. Med. High Impact Case Rep. 2019, 7, 1.

[12]  J. Ruzzolini, A. Laurenzana, E. Andreucci, S. Peppicelli, F. Bianchini, F. Carta, C. T. Supuran, M. N. Romanelli, C. Nediani, L. Calorini, J. Enzyme Inhib. Med. Chem. 2020, 35, 391.
         | Crossref | GoogleScholarGoogle Scholar | 31865754PubMed |

[13]  L. Van de Sande, S. Cosyns, W. Willaert, W. Ceelen, Drug Deliv. 2020, 27, 40.
         | Crossref | GoogleScholarGoogle Scholar | 31858848PubMed |

[14]  M. J. Wu, Y. H. Fan, S. G. Lv, B. Xiao, M. H. Ye, X. G. Zhu, Drug Deliv. 2016, 23, 2720.
         | Crossref | GoogleScholarGoogle Scholar |

[15]  G. F. Woodworth, G. P. Dunn, E. A. Nance, J. Hanes, H. Brem, Front. Oncol. 2014, 4, 126.
         | Crossref | GoogleScholarGoogle Scholar | 25101239PubMed |

[16]  J. H. Gao, Z. L. Wang, H. H. Liu, L. M. Wang, G. H. Huang, Drug Discov. Ther. 2015, 9, 205.
         | Crossref | GoogleScholarGoogle Scholar |

[17]  V. A. Trinh, S. P. Patel, W. J. Hwu, Expert Opin. Drug Saf. 2009, 8, 493.
         | Crossref | GoogleScholarGoogle Scholar | 19435405PubMed |

[18]  S. H. Bae, M. J. Park, M. M. Lee, T. M. Kim, S. H. Lee, S. Y. Cho, Y. H. Kim, Y. J. Kim, C. K. Park, C. Y. Kim, J. Korean Med. Sci. 2014, 29, 980.
         | Crossref | GoogleScholarGoogle Scholar | 25045231PubMed |

[19]  P. R. Debata, G. M. Curcio, S. Mukherjee, P. Banerjee, in Universe of Scales: From Nanotechnology to Cosmology, Springer Proceedings in Physics (Eds F. Freund, S. Langhoff) 2014, Vol. 150, Ch. 19, pp. 191–204 (Springer: Cham).

[20]  M. Chen, R. Chen, S. Wang, W. Tan, Y. Hu, X. Peng, Y. Wang, Int. J. Nanomedicine 2013, 8, 85.
         | Crossref | GoogleScholarGoogle Scholar | 23319860PubMed |

[21]  J. R. Kanwar, R. K. Kanwar, G. Mahidhara, C. H. A. Cheung, Aust. J. Chem. 2012, 65, 5.
         | Crossref | GoogleScholarGoogle Scholar |

[22]  J. Qu, L. Q. Zhang, Z. H. Chen, G. H. Mao, Z. Y. Gao, X. L. Lai, X. G. Zhu, J. M. Zhu, Drug Deliv. 2016, 23, 3408.
         | Crossref | GoogleScholarGoogle Scholar | 27181462PubMed |

[23]  S. Bhaskar, F. Tian, T. Stoeger, W. Kreyling, J. M. de la Fuente, V. Grazu, P. Borm, G. Estrada, V. Ntziachristos, D. Razansky, Part. Fibre Toxicol. 2010, 7, 3.
         | Crossref | GoogleScholarGoogle Scholar | 20199661PubMed |

[24]  L. Gastaldi, L. Battaglia, E. Peira, D. Chirio, E. Muntoni, I. Solazzi, M. Gallarate, F. Dosio, Eur. J. Pharm. Biopharm. 2014, 87, 433.
         | Crossref | GoogleScholarGoogle Scholar | 24833004PubMed |

[25]  G. H. Huang, N. Zhang, X. L. Bi, M. J. Dou, Int. J. Pharm. 2008, 355, 314.
         | Crossref | GoogleScholarGoogle Scholar |

[26]  S. Doktorovova, E. B. Souto, A. M. Silva, Eur. J. Pharm. Biopharm. 2014, 87, 1.
         | Crossref | GoogleScholarGoogle Scholar | 24530885PubMed |

[27]  H. K. Huang, J. Yan, P. Liu, B. Y. Zhao, Y. Cao, X. F. Zhang, Aust. J. Chem. 2017, 70, 1302.
         | Crossref | GoogleScholarGoogle Scholar |

[28]  S. J. Son, M. A. Brimble, S. Yang, P. W. R. Harris, T. Reddingius, B. W. Muir, O. E. Hutt, L. Waddington, J. Guan, G. P. Savage, Aust. J. Chem. 2013, 66, 23.
         | Crossref | GoogleScholarGoogle Scholar |

[29]  H. Krishnatreyya, S. Dey, P. Pal, P. J. Das, V. K. Sharma, B. Mazumder, Indian J. Pharm. Educ. Res. 2019, 53, s82.
         | Crossref | GoogleScholarGoogle Scholar |

[30]  E. Ye, X. J. Loh, Aust. J. Chem. 2013, 66, 997.
         | Crossref | GoogleScholarGoogle Scholar |

[31]  J. Liu, K. Wang, J. Luan, Z. Wen, L. Wang, Z. L. Liu, G. Y. Wu, R. X. Zhuo, J. Mater. Chem. B Mater. Biol. Med. 2016, 4, 1343.
         | Crossref | GoogleScholarGoogle Scholar | 32262990PubMed |

[32]  N. S. El-Salamouni, R. M. Farid, A. H. El-Kamel, S. S. El-Gamal, Int. J. Pharm. 2015, 496, 976.
         | Crossref | GoogleScholarGoogle Scholar | 26498372PubMed |

[33]  Y. M. Wang, A. L. Cory, Pharm. Dev. Technol. 1999, 4, 333.
         | Crossref | GoogleScholarGoogle Scholar |

[34]  L. Zhang, J. Zeng, Z. L. Zeng, F. H. Wang, D. S. Wang, C. Chen, C. Li, X. An, R. H. Xu, P. Huang, Y. Ba, Y. H. Li, Tumour Biol. 2016, 37, 11445.

[35]  L. Martín-Gomis, J. Ortiz, F. Fernández-Lázaro, A. Sastre-Santos, B. Elliott, L. Echegoyen, Tetrahedron 2006, 62, 2102.
         | Crossref | GoogleScholarGoogle Scholar |

[36]  C. E. Smith, A. Shkumatov, S. G. Withers, B. X. Yang, J. F. Glockner, S. Misra, E. J. Roy, C. H. Wong, S. C. Zimmerman, H. Kong, ACS Nano 2013, 7, 9599.
         | Crossref | GoogleScholarGoogle Scholar | 24083377PubMed |

[37]  X. Y. Zhang, J. P. Liu, H. Qiao, H. Liu, J. M. Ni, W. L. Zhang, Y. B. Shi, Powder Technol. 2010, 197, 120.
         | Crossref | GoogleScholarGoogle Scholar |

[38]  P. Panwar, B. Pandey, P. C. Lakhera, K. P. Singh, Int. J. Nanomedicine 2010, 5, 101.
         | 20309396PubMed |